FDA NDC Directory · JSON-LD · Markdown

KEVZARA

NDC 0024-5920 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namesarilumab
Labeler / ManufacturerSanofi-Aventis U.S. LLC
Marketing categoryBiologic License Application · App BLA761037
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsSARILUMAB (150 mg/1.14mL)
Marketing started20170522
Package count2

External sources

Source: openFDA. Public-domain (CC0).